Cargando…
Antivirals for COVID-19: A critical review
No specific drugs have been approved for coronavirus disease 2019 (COVID-19) to date as the development of antivirals usually requires time. Therefore, assessment and use of currently available antiviral drugs is critical for a timely response to the current pandemic. Here, we have reviewed anti-SAR...
Autores principales: | Frediansyah, Andri, Tiwari, Ruchi, Sharun, Khan, Dhama, Kuldeep, Harapan, Harapan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier, a division of RELX India, Pvt. Ltd on behalf of INDIACLEN.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831805/ https://www.ncbi.nlm.nih.gov/pubmed/33521390 http://dx.doi.org/10.1016/j.cegh.2020.07.006 |
Ejemplares similares
-
Remdesivir and its antiviral activity against COVID-19: A systematic review
por: Frediansyah, Andri, et al.
Publicado: (2021) -
Immunopharmacological considerations of general anaesthetics for surgical procedures in the times of COVID-19: Correspondence
por: Nainu, Firzan, et al.
Publicado: (2023) -
SARS-CoV-2 existence in sewage and wastewater: A global public health concern?
por: Dhama, Kuldeep, et al.
Publicado: (2021) -
Plant-based vaccines and antibodies to combat COVID-19: current status and prospects
por: Dhama, Kuldeep, et al.
Publicado: (2020) -
The role of disinfectants and sanitizers during COVID-19 pandemic: advantages and deleterious effects on humans and the environment
por: Dhama, Kuldeep, et al.
Publicado: (2021)